IRON – disc medicine, inc. (US:NASDAQ)
Stock Stats
News
Disc Medicine (NASDAQ:IRON) had its price target raised by analysts at Truist Financial Corporation from $86.00 to $114.00. They now have a "buy" rating on the stock.
What Disc Medicine (IRON)'s Bitopertin Fast-Track Review and Rising R&D Spend Mean for Shareholders [Yahoo! Finance]
Disc Medicine Reports Third Quarter 2025 Financial Results and Provides Business Update
Disc Medicine Announces Presentation of Initial Data from RALLY-MF Phase 2 Trial in Patients with Myelofibrosis (MF) and Anemia at the 67th American Society of Hematology (ASH) Annual Meeting
Disc Medicine (NASDAQ:IRON) had its "buy" rating reaffirmed by analysts at Stifel Nicolaus. They now have a $125.00 price target on the stock.
Form 4 Disc Medicine, Inc. For: Nov 11 Filed by: Yu Jonathan Yen-Wen
Form 144 Disc Medicine, Inc. Filed by: Yu Jonathan Yen-Wen
Form 10-Q Disc Medicine, Inc. For: Sep 30
Form 8-K Disc Medicine, Inc. For: Nov 06
Form SCHEDULE 13G/A Disc Medicine, Inc. Filed by: FMR LLC
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.